Medication info
Candesartan Tablets 8 mg (Candesartan Cilexetil)

Candesartan Tablets 8 mg (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›8mg / 1 tablet
Manufacturer / importer
Ildong Pharmaceutical Co., Ltd.
Appearance
White tablets that are round and convex on both sides
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201100299 · Approved 2011.01.20 · Insurance code 642904200

Summary

Main use
Treatment of essential hypertension and heart failure with impaired left ventricular systolic function
Who takes it
Adults · Children
Adult dose
This medicine should be taken at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Older adults: No dose adjustment is necessary. 3) Patients with intravascular volume depletion: For patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into account, up to a maximum of 32 mg once daily. 2) Older adults, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No dose adjustment is necessary.
Child dose
1. Essential hypertension 6) Children: The safety and efficacy have not been established in adolescents and children aged 18 years or younger. 2. Heart failure 3) Children: The safety and efficacy have not been established in adolescents and children aged 18 years or younger.

Ingredients

Manufacturer
Ildong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with impaired left ventricular systolic function

  • Essential hypertension
  • heart failure
  • left ventricular contraction dysfunction
  • reduced left ventricular ejection fraction
View approved original text

This medication helps to stabilize blood pressure in patients with essential hypertension, preventing cardiovascular complications. It can also be used in heart failure patients with reduced left ventricular contraction function, and is especially effective in cases where additional therapy beyond ACE inhibitors is needed or where ACE inhibitor tolerance is poor. By improving blood circulation and reducing the burden on the heart, it contributes to the overall improvement of heart function. Therefore, it is useful for the treatment of essential hypertension and certain heart failure patients.

How to take

Adult dose

This medicine should be taken at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Older adults: No dose adjustment is necessary. 3) Patients with intravascular volume depletion: For patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into account, up to a maximum of 32 mg once daily. 2) Older adults, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No dose adjustment is necessary.

Child dose

1. Essential hypertension 6) Children: The safety and efficacy have not been established in adolescents and children aged 18 years or younger. 2. Heart failure 3) Children: The safety and efficacy have not been established in adolescents and children aged 18 years or younger.

Precautions

This drug may cause serious harm or death to the fetus and newborn when administered to pregnant women, so the use should be discontinued immediately upon confirmation of pregnancy. Those who are allergic to this drug or its components, pregnant women or women of childbearing potential, nursing mothers, patients with severe liver impairment, patients with a history of angioedema, and individuals with certain genetic disorders should avoid taking this drug. Elderly patients, patients with hyperkalemia, liver disease, heart diseases, and those with impaired kidney function should use this drug cautiously and require regular blood tests and condition monitoring. This drug may cause side effects such as dizziness, back pain, and respiratory infections, and in rare cases, serious adverse reactions may occur. Therefore, if any abnormal symptoms arise, medical consultation should be sought immediately. In heart failure patients, hypotension, hyperkalemia, and renal function impairment may occur, making regular checks of blood potassium levels and kidney function important. When taken with other antihypertensive agents, the blood pressure-lowering effect may be increased; thus, caution is needed during administration. Particularly, when used in combination with potassium-sparing diuretics or potassium supplements, blood potassium levels may become dangerously elevated. Pregnant women or women planning to become pregnant should not take this medication, and nursing mothers should also ideally discontinue breastfeeding or avoid taking this medication. Safety and efficacy for children and adolescents under 18 years have not been established, so its use in this population is not recommended. Elderly patients may experience serious adverse effects, such as cerebral infarction, due to excessive blood pressure lowering, so careful monitoring is advised during administration. In cases of overdose, symptoms such as hypotension, dizziness, and tachycardia may appear, necessitating immediate visit to a medical institution for proper treatment, and this drug is not removed by dialysis. Keep out of reach of children, and avoid transferring to other containers as it may compromise product quality.

Side effects

Dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. Additionally, it is best to store the medication at room temperature between 1 and 30 degrees Celsius, avoiding excessively cold or hot conditions. This storage method preserves the medication's effectiveness.

Appearance and packaging

Appearance

White tablets that are round and convex on both sides

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.